Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat

British Journal of Pharmacology

Volumn 135, Issue 8, 2002, Pages 1935-1942

  Kanie, Noriyasu ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Aorta; Diabetes; Endothelin antagonist; Endothelin 1; Superoxide anion

Indexed keywords

2 BUTYL 7 [2 (2 CARBOXYPROPYL) 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE 6 CARBOXYLIC ACID; ACETYLCHOLINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIUM; LONG TERM CARE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0036255170     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704659     Document Type: Article

References (45)

1. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung
2. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells
3. Role of cytochrome P-450 in reperfusion injury of the rabbit lung
4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloroform extraction
5. Endothelial dysfunction in diabetes
6. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells
7. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall
8. Molecular pharmacology and pathophysiological significance of endothelin
9. Increased plasma levels of endothelin in diabetic patients with hypertension
10. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta
11. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
12. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats
13. Mechanisms underlying endothelial dysfunction in diabetes mellitus
14. Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension
15. Expression of phagocyte NADPH oxidase components in human endothelial cells
16. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes
17. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats
18. Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine
19. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes
20. Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats
21. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats
22. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats
23. Adenovirus-mediated gene transfer is augmented in basilar and carotid arteries of heritable hyperlipidemic rabbits
24. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1
25. Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats
26. Mechanisms underlying increased release of endothelin-1 from aorta in diabetic rats
27. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide
28. Endothelium-dependent relaxation in aorta of BB rat
29. B endothelin receptor antagonist
30. Augmented adenovirus-mediated gene transfer in atherosclerotic vessels
31. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats
32. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits
33. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo
34. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction
35. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta
36. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction
37. Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus
38. Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle
39. Elevated plasma endothelin in patient with diabetes mellitus
40. Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies
41. Decreased conversion of big endothelin-1 to endothelin-1 in patients with diabetes mellitus
42. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
43. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide
44. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats
45. Quantitative changes in pharmacodynamic parameters of noradrenaline in different rat aorta preparations: Influence of endogenous EDRF